Aladdin Healthcare Technologies SE announced company developed a prototype A.I powered data analysis platform for brain imaging. Company technological breakthrough means the prototype can process brain imaging data with the assistance of deep learning models. The novel application that can solve a number of issues regarding Alzheimer's Disease (AD) data analysis and computer aided diagnosis (CAD) with multiple analytics solutions for early detection and patient management. The following new features and attributes that the platform delivers, subject to CFDA and CE Mark approval, pave the way for a new generation of AD analytics tool that can significantly increase early stage diagnosis accuracy, workflow efficiency and lead to enhanced affordability. The key features include: Full and/or semi-automated analysis powered by recently developed A.I algorithms; Full support for multimodal imaging data including Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI); Highlighting the areas of potential disease, such as hippocampus area segmentation for Alzheimer's Disease, and other age-related diseases based on the A.I diagnosis model; and A cloud-based frontend and data privacy-preserved platform.